Drugs / GerEPO
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00229099 | Apr → Nov 2005 | anemia due to chronic disorder | Ministry of Health, Malaysia | Completed | Met primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GerEPO | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00229099 ↗ |
| Modality | Protein / enzyme biologic | “GerEPO, a biogeneric epoetin” PMID 17803464 ↗ Oct 2007 |